Clinical Trials Directory

Trials / Conditions / Stage IV Primary Peritoneal Cavity Cancer

Stage IV Primary Peritoneal Cavity Cancer

7 registered clinical trials studyying Stage IV Primary Peritoneal Cavity Cancer.

StatusTrialSponsorPhase
CompletedMetformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritone
NCT02122185
University of ChicagoPhase 2
WithdrawnVaccine Therapy and IDO1 Inhibitor INCB024360 in Treating Patients With Epithelial Ovarian, Fallopian Tube, or
NCT01982487
Roswell Park Cancer InstitutePhase 1 / Phase 2
CompletedSirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian Epithelial, Fallopian Tube, or Pri
NCT01536054
Roswell Park Cancer InstitutePhase 1
CompletedSunitinib Malate in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal
NCT00388037
National Cancer Institute (NCI)Phase 2
CompletedAFP464 in Treating Patients With Metastatic or Refractory Solid Tumors That Cannot Be Removed By Surgery
NCT00348699
National Cancer Institute (NCI)Phase 1
CompletedCisplatin and Flavopiridol in Treating Patients With Advanced Ovarian Epithelial Cancer or Primary Peritoneal
NCT00083122
National Cancer Institute (NCI)Phase 2
CompletedFenretinide in Treating Patients With Recurrent or Metastatic Ovarian Epithelial or Primary Peritoneal Cancer
NCT00026091
National Cancer Institute (NCI)Phase 2